4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...

4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements

4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...

4/29/202553 Original Research Drugs Approved in China in Early 2025

4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China

4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...

4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...

4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...

4/29/2025Innovent Announces NMPA Approval of Limertinib

4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...

4/29/2025Hengrui Secures Approval for Hong Kong IPO

More>>

4/29/2025High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Cris...

4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...

4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...

4/25/2025Cell Therapy to AI: How J&J Has Been Sourcing the Transformational Sci...

4/24/2025China Biopharma Tracker – March 2025 (PharmaDJ)

4/24/2025US Capital Crunch Pushes China Biotechs to Roundabout Financings (Phar...

4/23/2025Cheaper Chinese HPV Vaccines Turn Merck's Gardasil From Boom to Bust (...

4/22/2025China Broadens Healthcare Access: Foreign Doctors and Drug Import Refo...

4/22/2025As US Decouples, China Strengthens Biotech Ties With Japan (The Diplom...

4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)

4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...

More>>